Anebulo Pharmaceuticals Inc (ANEB NASDAQ) stock market data APIs
$2.222
0.03(1.4%)
as of December 18, 2025
Try our APIs with
free plan!
Anebulo Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Prev. Close
2.222
Open
2.2521
High
2.4194
Low
1.9166
52 wk Range
0.9001-3.42
Market Cap
90 797 K
Shares Outstanding
41 085 K
EPS
-0.05
Beta
-0.87
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Anebulo Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Anebulo Pharmaceuticals Inc data using free add-ons & libraries
Get Anebulo Pharmaceuticals Inc Fundamental Data
Anebulo Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Anebulo Pharmaceuticals Inc News
New
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying
(RTTNews) - U.S. after-hours trading on Wednesday saw a wave of gains across several small-cap and micro-cap biotech names, with a mix of catalyst-driven moves and sentiment-based rebounds. While a fe...
Anebulo Pharmaceuticals GAAP EPS of -$0.05 beats by $0.07
* Anebulo Pharmaceuticals press release [https://seekingalpha.com/pr/20307273-anebulo-pharmaceuticals-reports-first-quarter-fiscal-year-2026-financial-results-and-recent] (ANEB [https://seekingalpha...
S&P Futures Steady After Rate-Cut Rally, Trump-Xi Call in Focus
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.02% this morning, taking a breather after yesterday’s gains, with investors turning their ...
S&P Futures Tick Higher With Trump-Xi Call in Focus
September S&P 500 E-Mini futures (ESU25) are trending up +0.17% this morning, extending yesterday’s gains, while investors await a phone call between U.S. President Donald Trump and Chinese Presiden...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
